Abstract
Xanthine oxidase (XO) plays an important role in several diseases such as hyperuricemia, gout, cardiovascular and inflammation. And the XO inhibitors which can block the generation of uric acid and decrease superoxide anion in vivo show considerable promise in the therapy of these diseases. Here we present an overview of the xanthine oxidase inhibitors and also review the various analytical methods to screen xanthine oxidase inhibitors. The xanthine oxidase inhibitors can be divided into synthetic xanthine oxidase inhibitors and natural xanthine oxidase inhibitors. And both of the classical and novel analytical methods are offered.
Keywords: Analytical methods, natural xanthine oxidase inhibitors, non-purine inhibitors, purine derivatives, screening; xanthine oxidase.
Current Traditional Medicine
Title:Xanthine Oxidase Inhibitors and the Analytical Methods to Screen Them: A Review
Volume: 1 Issue: 1
Author(s): Chen Xu, Shu Liu, Fengrui Song and Zhiqiang Liu
Affiliation:
Keywords: Analytical methods, natural xanthine oxidase inhibitors, non-purine inhibitors, purine derivatives, screening; xanthine oxidase.
Abstract: Xanthine oxidase (XO) plays an important role in several diseases such as hyperuricemia, gout, cardiovascular and inflammation. And the XO inhibitors which can block the generation of uric acid and decrease superoxide anion in vivo show considerable promise in the therapy of these diseases. Here we present an overview of the xanthine oxidase inhibitors and also review the various analytical methods to screen xanthine oxidase inhibitors. The xanthine oxidase inhibitors can be divided into synthetic xanthine oxidase inhibitors and natural xanthine oxidase inhibitors. And both of the classical and novel analytical methods are offered.
Export Options
About this article
Cite this article as:
Xu Chen, Liu Shu, Song Fengrui and Liu Zhiqiang, Xanthine Oxidase Inhibitors and the Analytical Methods to Screen Them: A Review, Current Traditional Medicine 2015; 1 (1) . https://dx.doi.org/10.2174/2215083801999150527115400
DOI https://dx.doi.org/10.2174/2215083801999150527115400 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
Current Medicinal Chemistry Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Heart Failure in South America
Current Cardiology Reviews Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders
Mini-Reviews in Medicinal Chemistry Epidermolysis Bullosa: The Pediatricians Role
Current Pediatric Reviews Multiple Drug Resistance Associated with Function of ABC-Transporters in Diabetes Mellitus: Molecular Mechanism and Clinical Relevance
Infectious Disorders - Drug Targets Current Indications for Implantable Cardioverter Defibrillators in Non-Ischemic Cardiomyopathies and Channelopathies
Reviews on Recent Clinical Trials Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker
Current Molecular Medicine Nerve Growth Factor: A Focus on Neuroscience and Therapy
Current Neuropharmacology Melatonin Causes Gene Expression in Aged Animals to Respond to Inflammatory Stimuli in a Manner Differing from that of Young Animals
Current Aging Science Mechanisms of Enhanced Vasoconstriction in the Mouse Model of Atherosclerosis: the Beneficial Effects of Sildenafil
Current Pharmaceutical Biotechnology Editorial[Hot Topic:Stem Cell Therapy for Cardiovascular Diseases:Are We Still at the Beginning of A Long Road?(Guest Editor:Lino M Goncalves)
Cardiovascular & Hematological Disorders-Drug Targets Clinical and Pharmacological Aspects of Immunoprophylaxis for Respiratory Syncytial Virus Infection in High-Risk Infants
Current Drug Metabolism Outline of Proteins and Signaling Pathways Involved in Heart Failure
Current Protein & Peptide Science CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation?
Anti-Cancer Agents in Medicinal Chemistry Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology Host Innate Immune Responses to Microbial Pathogens
Current Vascular Pharmacology New Developments in Anthracycline-Induced Cardiotoxicity
Current Medicinal Chemistry Editorial: Cocaine and Cerebral Small Vessel: Is it a Negative Factor for Intravenous Thrombolysis?
Current Vascular Pharmacology